Capitalizing on Success of Systemic Therapy to Improve Outcomes of Intermediate-Stage HCC

JCO Oncol Pract. 2022 Jan;18(1):43-44. doi: 10.1200/OP.21.00451. Epub 2021 Jul 23.

Authors

Patrick M Grierson¹, Haeseong Park¹

Affiliation

¹ Siteman Cancer Center, Washington University in St Louis, St Louis, MO.

PMID: 34297599
DOI: 10.1200/OP.21.00451

No abstract available

Publication types

Comment

MeSH terms

Carcinoma, Hepatocellular*
Humans
Liver Neoplasms*